Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 12, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 213
- −3 vs. Q1 2021
- Portfolio value
- $10.2B
- +$792.7M (+8.4%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ELVElevance Health, Inc. | Stock | 465,976 | $177.9M | 1.7% | +80,428+20.9% | Added | History |
| BIIBBiogen Inc. | COM | 528,100 | $182.9M | 1.8% | −30,300−5.4% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 202,095 | $185.9M | 1.8% | −18,680−8.5% | Reduced | History |
| MGNXMacrogenics Inc | COM | 7,376,026 | $198.1M | 1.9% | +1,348,100+22.4% | Added | History |
| FATEFate Therapeutics Inc | COM | 2,613,536 | $226.8M | 2.2% | +404,200+18.3% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,352,992 | $239.9M | 2.3% | −184,100−4.1% | Reduced | History |
| INCYIncyte Corp | COM | 2,971,400 | $250.0M | 2.4% | −34,300−1.1% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,549,092 | $262.6M | 2.6% | −78,022−4.8% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 974,038 | $293.3M | 2.9% | +19,484+2.0% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,017,751 | $293.7M | 2.9% | −256,800−7.8% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,733,694 | $349.6M | 3.4% | +356,990+25.9% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,930,245 | $396.1M | 3.9% | +946,011+10.5% | Added | History |
| MRNAModerna, Inc. | Stock | 2,542,300 | $597.4M | 5.8% | −267,650−9.5% | Reduced | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Curevac N VN2451R105 | COM | – | $39.0K |
Sold out since Q1 2021 (15)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| DVADavita Inc. | COM | 367,600 | $39.6M | 0.4% | History |
| NUANNuance Communications, Inc. | COM | 468,885 | $20.5M | 0.2% | History |
| IRTCiRhythm Holdings, Inc. | COM | 87,631 | $12.2M | 0.1% | History |
| TRHCTabula Rasa HealthCare, Inc. | COM | 227,178 | $10.5M | 0.1% | History |
| Curevac N VN2451R105 | COM | 28,900 | $2.64M | <0.1% | – |
| GW Pharmaceuticals PLC36197T103 | ADS | 10,000 | $2.17M | <0.1% | – |
| KYNBKyntra Bio, Inc. | COM | 60,000 | $2.08M | <0.1% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 15,500 | $2.00M | <0.1% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 20,300 | $1.51M | <0.1% | History |
| CAHCardinal Health Inc | Stock | 24,000 | $1.46M | <0.1% | History |
| YI111, Inc. | ADS | 85,000 | $1.17M | <0.1% | History |
| QUREuniQure N.V. | SHS | 34,500 | $1.16M | <0.1% | History |
| PAYXPaychex Inc | Stock | 3,900 | $382.0K | <0.1% | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 8,000 | $185.0K | <0.1% | History |
| VYGRVoyager Therapeutics, Inc. | COM | 31,800 | $150.0K | <0.1% | History |